Zacks.com on MSN
3 Biotech Stocks With Major 2026 Catalysts
Biotech's 2025 rebound sets the stage for Denali Therapeutics and two peers, with key FDA decisions and pipeline catalysts ...
Researchers at Wageningen University & Research (WUR) reported a discovery that an ancient ancestor of the cannabis plant ...
As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...
Compare the 2026 BSc Microbiology and BSc Biotechnology. To help you choose between a career in genetic engineering and ...
Where do the well-known cannabis compounds THC, CBD and CBC come from? Researchers at Wageningen University & Research have experimentally ...
Canadians learned how plants make a rare natural substance—mitraphylline—with its potential for fighting cancer as a ...
Seattle, USA-based biotech Omeros Corp saw its shares leap 75.5% to $15.36 by close of trading Wednesday, as it revealed that ...
The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...
Mitraphylline is part of a small and unusual family of plant chemicals known as spirooxindole alkaloids. These molecules are defined by their distinctive twisted ring shapes, which help give them ...
Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
XORTX Therapeutics Inc. ("XORTX" or the "Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results